secwatch.observer — SEC 8-K summary
======================================

Issuer:     Boundless Bio, Inc. (BOLD)
CIK:        0001782303
Form:       8-K
Filed at:   2024-10-15T23:59:59+00:00
Accession:  0000950170-24-114466
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Boundless Bio CFO Jami Rubin steps down; David Hinkle named principal financial officer
--------------------------------------------------------------------------------

- Jami Rubin resigned as CFO and Treasurer effective October 11, 2024.
- David Hinkle, SVP Finance & Controller, appointed as Treasurer, principal financial officer and principal accounting officer.
- Rubin eligible for severance per company's Severance Plan as a Tier 2 employee.
- Hinkle joined Boundless Bio in 2021; prior roles at Crinetics Pharmaceuticals, Ignyta, Receptos.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782303/000095017024114466/0000950170-24-114466-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782303/000095017024114466/bold-20241011.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-114466

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer